UK Companies House feature
RIGHT MEDICINE PHARMACY LIMITED
Cash
£1M
+135% vs 2024
Net assets
£3M
-9.9% vs 2024
Employees
173
+6.8% vs 2024
Profit before tax
—
Period ending 2025-02-28
Profile
- Company number
- SC228623
- Status
- Active
- Incorporation
- 2002-02-28
- Last accounts made up
- 2025-02-28
- Account category
- GROUP
- Primary SIC
- 47730
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2025-02-28
| Metric | Trend | 2020-02-28 | 2021-02-28 | 2022-02-28 | 2023-02-28 | 2024-02-28 | 2025-02-28 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | |
| Net profit | £303,091 | £767,229 | — | — | -£233,855 | -£108,928 | |
| Cash | £1,146,959 | £1,988,342 | — | — | £596,714 | £1,402,028 | |
| Total assets less current liabilities | £7,539,576 | — | — | — | £9,797,556 | £10,468,808 | |
| Net assets | £2,268,397 | £2,840,234 | — | — | £3,823,210 | £3,446,402 | |
| Equity | — | — | £2,941,729 | £2,157,197 | £3,823,210 | £3,446,402 | |
| Average employees | 123 | 140 | — | — | 162 | 173 | |
| Wages | £2,149,203 | £2,426,318 | — | — | £4,779,452 | £5,398,180 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Thomson Cooper
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.”
Subsidiaries
- Web Pharmacy Limited · 58.33% held · United Kingdom
- RMP2 Limited · 100% held · United Kingdom
- LP North Nine Limited · 100% held · United Kingdon
- LP North Ten Limited · 100% held · United Kingdom
- Pathhead Pharmacy Limited · 100% held · United Kingdom
Significant events
- “On 30 August 2024 Right Medicine Pharmacy Limited acquired 100% of the share capital in Pathhead Pharmacy Limited. On the same day the assets and liabilities were hived up into Right Medicine Pharmacy Limited.”
- “On 31 March 2025, Right Medicine Pharmacy Limited acquired 100% of the share capital of Slamannan Village Pharmacy Limited.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| EMBREY, Elizabeth | Secretary | 2017-07-25 | — | — |
| BURTON, Jonathan | Director | 2002-02-28 | Mar 1977 | British |
| EMBREY, Michael | Director | 2004-03-01 | Sep 1978 | British |
| STEPHENSON, Richard Ian | Director | 2024-05-17 | Sep 1984 | British |
| WICKS, Noel James | Director | 2002-02-28 | May 1977 | British |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BURTON, Jonathan | Secretary | 2002-02-28 | 2004-09-01 |
| EMBREY, Michael | Secretary | 2004-03-01 | 2017-07-25 |
| OSWALDS OF EDINBURGH LIMITED | Corporate Nominee Secretary | 2002-02-28 | 2002-02-28 |
| WICKS, Robin Laurie Spencer | Director | 2004-03-28 | 2006-02-01 |
| JORDANS (SCOTLAND) LIMITED | Corporate Nominee Director | 2002-02-28 | 2002-02-28 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Noel James Wicks | Individual | Shares 25–50% | 2016-04-06 | Ceased 2025-04-15 |
| Mr Michael Embrey | Individual | Shares 25–50% | 2016-04-06 | Ceased 2025-04-15 |
| Mr Jonathan Burton | Individual | Shares 25–50% | 2016-04-06 | Ceased 2017-04-01 |
Filing timeline
Last 20 of 120 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-18 | SH03 | capital | capital return purchase own shares |
| 2026-03-17 | SH06 | capital | capital cancellation shares |
| 2026-03-05 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-11-19 | AA | accounts | accounts with accounts type group |
| 2025-10-22 | MR04 | mortgage | mortgage satisfy charge full |
| 2025-10-15 | MA | incorporation | memorandum articles |
| 2025-10-15 | RESOLUTIONS | resolution | resolution |
| 2025-10-07 | SH01 | capital | capital allotment shares |
| 2025-10-06 | SH10 | capital | capital variation of rights attached to shares |
| 2025-10-06 | SH08 | capital | capital name of class of shares |
| 2025-05-23 | SH06 | capital | capital cancellation shares |
| 2025-05-23 | SH03 | capital | capital return purchase own shares |
| 2025-04-15 | PSC08 | persons-with-significant-control | notification of a person with significant control statement |
| 2025-04-15 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-04-15 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-02-28 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-11-28 | AA | accounts | accounts with accounts type group |
| 2024-05-17 | AP01 | officers | appoint person director company with name date |
| 2024-02-29 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-11-28 | AA | accounts | accounts with accounts type group |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory